Overview
Sarracenia purpurea, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family Sarraceniaceae. Sarracenia purpurea attract and trap insects within their pitchers, or fused leaves, to consume nitrogen during the digestion process . It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities . It was used as an injectable pain reliever and during the 19th century, Sarracenia purpurea was used as a treatment of smallpox . Compounds extracted from Sarracenia purpurea include phenolic glycosides, flavonoid glycosides, and iridoids. In vitro, there is evidence of glycosides potentiating glucose uptake with potential antidiabetic properties . Cytoprotection in an in vitro model of diabetic neuropathy has also been studied. However, the use of Sarracenia Purpurea extracts in the clinical setting are limited.
Indication
No approved therapeutic indications.
Associated Conditions
- Pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Deseret Biologicals, Inc. | 43742-2263 | ORAL | 12 [hp_X] in 1 mL | 5/7/2025 | |
Deseret Biologicals, Inc. | 43742-2108 | ORAL | 12 [hp_X] in 1 mL | 5/27/2025 | |
Newton Laboratories, Inc. | 55714-4748 | ORAL | 15 [hp_X] in 1 mL | 8/20/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
SARAPIN | high chemical company | 00226882 | Solution - Intramuscular | 100 % | 12/31/1942 |
SARRACENIA PURPUREA GRAN (1CH-30CH) | homeocan inc. | 01952846 | Tablet - Oral | 1 CH / TAB | 12/31/1991 |
NEPENTHES GRANULES 1DH-30CH | dolisos laboratoires s.a. | 00769703 | Tablet - Oral | 1 DH / DH | 12/31/1988 |
NEPENTHES | dolisos canada inc. | 02234628 | Granules
,
Globules
,
Liquid - Oral | 1 X | 1/5/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.